Allocation Policy Implementation During a Severe Chemotherapy Shortage

• by Eric C. Blackstone, Yating Wang, Eno-Abasi Inyang, Andrew G. Shuman, Michael Casey, Gregory A. Abel, Andrew Hantel

• October 19, 2026

Bringing CAR T Closer to Home

CAR T Vision aims to widen access to cell therapy by expanding community-based delivery, easing operational barriers, and building sustainable funding models

• October 13, 2026

• 8 min

Musings From the Power List: Jason Bock

Jason Bock shares his outlook on RNA-targeting therapies, personalized medicine, and the future of drug development

• by Jason Bock

• October 14, 2026

• 14 min

Immune and cellular determinants of response to HMA-venetoclax regimens in acute myeloid leukemia

• by Alfredo Marchetti, Francesca Lazzaroni, Matteo Claudio Da Via', Marta Lionetti, Giulia Maggioni, Alessia Campagna, Denise Ventura, Giorgio A. Croci, Alessio Marella, Akihiro Maeda, Antonio Matera, Emanuele Calvi, Margherita Scopetti, Filippo Viviani, Nicolò Rampi, Davide Bonometti, Elena Benzoni, Manuela Zappa, Sonia Fabris, Marzia Barbieri, Stefania Pioggia, Claudia Leoni, Antony Ricchiuti, Matteo G. D. Porta, Mariarita Sciumè, Francesco Passamonti, Nicola S. Fracchiolla, Niccolò Bolli

• October 13, 2026